Skip to main content

Advertisement

Log in

Mucopolysaccharidosis type IIIC in chinese mainland: clinical and molecular characteristics of ten patients and report of six novel variants in the HGSNAT gene

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Background

Mucopolysaccharidosis type IIIC (MPS IIIC; Sanfilippo syndrome C) is a rare lysosomal storage disease caused by mutations in the heparan-α-glucosaminide N-acetyltransferase (HGSNAT) gene, resulting in the accumulation of heparan sulfate. MPS IIIC is characterized by severe neuropsychiatric symptoms and mild somatic symptoms.

Methods

Our study analyzed the clinical presentation and biochemical characteristics of ten Chinese MPS IIIC patients from eight families. Whole exome sequencing was applied to identify the variants in HGSNAT gene. In one patient with only one mutant allele identified firstly, whole genome sequencing was applied. The pathogenic effect of novel variants was evaluated in silico.

Results

The mean age at the onset of clinical symptoms was 4.2 ± 2.5 years old, and the mean age of diagnosis was 7.6 ± 4.5 years old, indicating a delay of diagnosis. The most common onset symptoms were speech deterioration, and the most frequent presenting symptoms are speech deterioration, mental deterioration, hyperactivity and hepatomegaly, sequentially. All mutant alleles of 10 patients have been identified. There were eleven different HGSNAT variants, and the most common one was a previously reported variant c.493 + 1G > A. There were six novel variants, p.R124T, p.G290A, p.G426E, c.743 + 101_743 + 102delTT, c.851 + 171T > A and p.V582Yfs*18 in our cohort. Extraordinarily, two deep intron variants were identified in our cohort, with the variant c.851 + 171T > A identified by whole genome sequencing.

Conclusion

This study analyzed the clinical, biochemical, and genetic characteristics of ten Chinese MPS IIIC patients, which would assist in the early diagnosis and genetic counselling of MPS IIIC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

The data for this study are available from the corresponding author on reasonable request.

Code Availability

Not applicable.

Abbreviations

MPS IIIC:

Mucopolysaccharidosis type IIIC

HGSNAT:

heparan-α-glucosaminide N-acetyltransferase

CPC:

cetylpyridinium chloride

DMB:

1,9-dimethylmethene blue chloride

GAGs:

glycosaminoglycans

HS:

heparan sulfates

DS:

dermatan sulfates

CS:

Chondroitin sulfates

WES:

Whole exome sequencing

WGS:

Whole genome sequencing

References

Download references

Acknowledgements

We are greatly indebted to the patients and their families who participated in this study for their invaluable contributions, which made the work described in this manuscript possible.

Funding

This work was supported by the Shanghai Municipal Health Commission [grant number 202240361]; the Shanghai Science & Technology Commission [grant number 20ZR1446300]; and the Shanghai Municipal Education Commission [grant number 20152520]. These funding did not have any role in the conduct of the research, preparation of the article or the decision to submit the article for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huiwen Zhang.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Consent to participate

Written informed consent was obtained from the guardians of children.

Consent to publication

Written informed consent was obtained from the guardians of children.

Competing interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liang, Y., Gao, X., Lu, D. et al. Mucopolysaccharidosis type IIIC in chinese mainland: clinical and molecular characteristics of ten patients and report of six novel variants in the HGSNAT gene. Metab Brain Dis 38, 2013–2023 (2023). https://doi.org/10.1007/s11011-023-01204-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-023-01204-8

Keywords

Navigation